Migraine and haemostasis

Cephalalgia

Volumn 21, Issue 6, 2001, Pages 630-636

  Crassard, I ^a   Conard, J ^b   Bousser, Marie Germaine ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

^b HÔTEL DIEU   (France)

Author keywords

Antibody; Antiphospholipid; Haemostasis; Migraine; Platelets; Stroke; Thrombophilia

Indexed keywords

PHOSPHOLIPID ANTIBODY;

BRAIN INFARCTION; HEMOSTASIS; HUMAN; MIGRAINE; REVIEW; RISK FACTOR; THROMBOCYTE; THROMBOPHILIA; THROMBOSIS;

ANTIBODIES, ANTIPHOSPHOLIPID; BLOOD PLATELETS; CEREBRAL INFARCTION; HEMOSTASIS; HUMANS; MIGRAINE DISORDERS; PROTHROMBIN;

EID: 0034881198     PISSN: 03331024     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-2982.2001.00205.x     Document Type: Review

References (73)

1. Migrainous stroke
2. Migraine and stroke in young women: Case-control study
3. Case-control study of migraine and risk of ischaemic stroke in young women
4. History of migraine and risk of cerebral ischaemia in young adults
5. Association between migraine and stroke in a large-scale epidemiological study of the United States
6. A controlled study of ischemic stroke risk in migraine patients
7. Migraine et anomalies mitochondriales
8. Migraine and the mitral valve prolapse syndrome
9. Potential source of cerebral embolism in migraine with aura: A transcranial doppler study
10. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain
11. Platelets as a model for neurones?
12. Migraine, a platelet disorder
13. Platelet aggregability in migraine
14. Platelet activation in migraine
15. Platelet aggregability, disaggregability and serotonin uptake in migraine
16. Platelet aggregation of migraineurs during and between attacks
17. 5-Hydroxytryptamine levels and platelet aggregation responses in subjects with acute migraine headache
18. Platelet aggregation in response to 5-HT in migraine patients taking oral contraceptives
19. Platelet aggregation in migraine patients during the headache-free interval
20. Evidence of enhanced platelet aggregation and platelet sensitivity in migraine patients
21. Sensitivity to PAF is increased in migraine patients
22. Cyclic changes in platelet dynamics and the pathogenesis and prophylaxis of migraine
23. 'Complicated migraine', its association with increase platelet aggregability and abnormal plasma coagulation factors
24. Platelet adrenoreceptor function in migraine patients
25. Platelet aggregation study in migraine patients between and during attacks
26. Different profiles of platelet granule secretion in migraine with aura and without aura
27. Platelet function in classic migraine during attack-free periods
28. Platelet aggregation in patients with migraine during pain attack and without pain
29. Platelet fibrinogen receptors in migraine patients
30. Increased platelet glycoprotein IIb reflects an abnormality of the platelet membrane in migraine
31. Platelet membrane lipid composition and the frequency of migraine
32. ATP hyposecretion from platelet dense bodies. Evidence for the purinergic hypothesis and a marker of migraine
33. Reduced collagen induced aggregation in whole blood in migraine: Possible relationship with increased platelet levels and the NO pathway
34. Handling of 5-hydroxytryptamine by platelets in migraine
35. The influence of acute smoking on leucocytes, platelets and the endothelium
36. Platelet activity in migraine
37. The platelet release reaction during migraine attacks
38. Effects of different doses of acetylsalicylic acid on frequency of migraine attack, platelet prostaglandin synthesis and platelet aggregation
39. Thromboxane synthase inhibition: Potential therapy in migraine
40. Comparative neuropharmacology of dihydroergotamine and sumatriptan (GR 32, 175)
41. Low-dose of aspirin for migraine prophylaxis
42. Propanolol and acetylsalicylic acid in migraine prophylaxis
43. The use of platelet inhibitors in migraine
44. Combined low-dose acetylsalicylic acid and dihydroergotamine in migraine prophylaxis. A double-blind, placebo-controlled crossover study
45. Effects on methysergide on platelets incubated with reserpine
46. Migraine is not a platelet disorder
47. Migraine ou accidents ischémiques transitoires au cours d'une thrombocytémie essentielle. Action de la ticlopidine
48. Can transient ischaemic attacks and classical migraine always be distinguished?
49. The 'primary' antiphospholipid syndrome: Major clinical and serological features
50. Primary anti-phospholipid syndrome
51. Antiphospholipid antibodies: Anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders
52. Primary antiphospholipid syndrome: Features of patients with raised anticardiolipin antibodies and no other disorder
53. The spectrum of neurological disease associated with antiphospholipid antibodies
54. Cerebrovascular neurologic disease associated with antiphospholipid antibodies: 48 cases
55. Migrainous phenomena in systemic lupus erythematosus
56. Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease and the primary antiphospholipid syndrome
57. Lack of association between anticardiolipin antibodies and migraine in systemic lupus erythematosus
58. Cerebral infarction associated with lupus anticoagulant-preliminary report
59. Cerebral infarction in systemic lupus: Association with anticardiolipin antibodies
60. Migraine and antiphospholipid antibodies
61. Lupus anticoagulant, antiphospholipid antibodies and migraine
62. Neurological disease associated antiphospholipid antibodies
63. Anticardiolipin antibodies in migraine
64. Lack of association between antiphospholipid antibodies and migraine
65. Absence d'anticorps antiphospholipides au cours de la migraine
66. Anticuerpos anticardiolipina y su asociacion con cefalea
67. Migraine and anticardiolipin antibodies - Case reports of 13 patients and the prevalence of antiphospholipid antibodies in migraineurs
68. Role of anticardiolipin antibodies in young persons with migraine and transient focal neurologic events
69. Arg506Gln Factor V mutation (Factor V Leiden) in patients with ischaemic cerebrovascular disease and survivors of myocardial infarction
70. Migraine and prothombotic risk factors
71. Genetics abnormalities of the protein C system: Shared risk factors in young adults with migraine with aura and with ischemic stroke?
72. Frequency of Factor V Leiden in juvenile migraine with aura
73. The factor V Leiden is not a major risk factor for migrainous cerebral infarction